Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series : World’s leading Event Organizer
Cancer screening aims to detect cancer before symptoms appear, This may involve blood tests, urine tests, other tests, or medical imaging. The benefits of screening in terms of cancer prevention, early detection and subsequent treatment must be weighed against any harms. Universal screening, mass screening or population screening involves screening everyone, usually within a specific age group. Selective screening identifies people who are known to be at higher risk of developing cancer, such as people with a family history of cancer. Screening can lead to false positive results and subsequent invasive procedures. Screening can also lead to false negative results, where an existing cancer is missed. Controversy arises when it is not clear if the benefits of screening outweigh the risks of the screening procedure itself, and any follow-up diagnostic tests and treatments. Screening tests must be effective, safe, well-tolerated with acceptably low rates of false positive and false negative results. If signs of cancer are detected, more definitive and invasive follow-up tests are performed to reach a diagnosis. Screening for cancer can lead to cancer prevention and earlier diagnosis. Early diagnosis may lead to higher rates of successful treatment and extended life. However, it may also falsely appear to increase the time to death through lead time bias or length time bias. Cancer risk is measured in different ways. The findings from surveys and studies about cancer risk are studied and the results are explained in different ways. Some of the ways risk is explained include absolute risk, relative risk , and odds ratios. Absolute risk: This is the risk a person has of developing a disease. Relative risk: This is often used in research studies to find out whether a trait or a factor can be linked to the risk of a disease.
The field of translational Cancer screening is rapidly progressing, yet the systematic application of current knowledge to improve patient care remains a formidable challenge. National symposiums and Workshops provide a dedicated forum for the advancement, implementation and exchange of information about cancer screening and its allied areas. Around 20 National symposiums and Workshops are going to be held across the globe which includes “The Translantic Symposium On Colorectal Cancer Prevention” is an idea of detection and prevention, Head And Neck Cancer Alliance which seeks to enable an organized and strategic alliance of all stakeholders to dramatically shift the stage of discovery of head and neck cancers through united and collaborative efforts in prevention, early detection and research.
OMICS Group International is a unique blend of international conferences and open access publications. OMICS Group was established in the year 2007 with an aim of “Making the information on Sciences and Technology-Open Access” It publishes journals in all aspects of Science, Engineering, Management and Technology; it publishes around 400 online open access journals. OMICS Group organizes International Conferences across the globe. Each conference has people from around the globe, and knowledge is exchanged through symposiums, workshops, poster presentations, by people who are leading researchers, noble prize winners, Educational instructors, Research Scholars, and leading scientists. OMICS Group organizes more than 300 conferences per year.
Relevant Associations & Societies:-
1. Center for disease control and prevention association.
2. American medical association.
3. American cancer society.
4. Canadian task force on preventive health care.
5. American college of preventive medicine.
6. National institute of health.
7. American urological association.
8. American gastro enterological association.
9. Colorectal cancer association of Canada.
World Congress on Breast Cancer August 03-05, 2015 Birmingham, UK
Prostate screening cancer using prostate antigen test (Amsterdam, the Netherlands) 30 Sep,2013.
Impact 2014 Breast Cancer Conference (Brussels, Belgium) 08 May - 10 May,2014.
Europeon[ Multidisciplinary Cancer Conferences (Stockholm, Sweden) - 23 Sep - 27 Se,2011.
Europeon Lung Cancer Conference (Geneva, Switzerland) - 26 Mar - 29 Mar,2014.
Ovarian Cancer Screening (LONDON, UK) November 29-30, 2011.
Prostate Cancer Screening Communication Conference (ATLANTA, GEORGIA) June 13-14,2011.
19th Macro Trend Conference on Health and Medicine: Paris 2014 Paris, France.
29th Hypnosis within the world of dentistry London, United Kingdom.
8th SCEH 65th Annual Workshops and Scientific Session San Antonio, United States of America, 2014.
17th Australasian Military Medicine Association Conference 2014 Sydney, Australia, 2014.
30th International Conference on Humanitarian Medical Missions Singapore, Singapore, 2014.
18th International Conference and Exhibition on Dentistry 2015 Dubai, United Arab Emirates.
World Congress on Breast Cancer Aug 3-5, 2015 Birmingham, UK
Prostate Cancer Congress during June22-24, 2015 at Florida USA
<a href="http://cancer.global-summit.com/europe/>8th Euro Global Summit on Cancer Therapy
5th world Congress on Cancer Therapy
5th Global Summit on Cancer therapy
World Drug Delivery Summit during August 17-19, 2015 at Houston, USA.
International Conference on Urology to be held from July 20-22nd , 2015 in Barcelona, Spain
8th Euro Global Summit on Cancer Therapy
This page will be updated regularly.
This page was last updated on March 21, 2023